SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Servier. (11/2/17). "Press Release: Servier Germany to Co-promote Novartis’ Blockbuster Entresto".

Region Region Germany
Organisations Organisation Servier Deutschland GmbH
  Group Servier (Group)
  Organisation 2 Novartis Deutschland GmbH
  Group Novartis (Group)
Products Product Entresto®
  Product 2 cardiovascular drug
Person Person Kirst, Oliver (Servier 201711 General Manager of Servier Germany)

Servier Germany will start to co-promote Novartis’ potential blockbuster Entresto® (Sacubitril/Valsartan) used in cardiovascular diseases in Germany from November 1st 2017 onwards.

Servier was chosen for “its excellent knowledge and contacts in the field of cardiovascular diseases,” said Dr. Rüdiger Merkel, Head Cardio-Metabolic Franchise from Novartis Germany in an internal joined meeting with Servier and Novartis in Alpbach, Tirol/Austria. “Together, we will be able to inform cardiologists and GPs even in a more targeted way”, he added.

“Servier Germany is very pleased about this cooperation, as this agreement once again underscores our proven high expertise in the field of cardiovascular diseases”, said Oliver Kirst, General Manager of Servier Germany. “As still demonstrated within our ongoing cooperation with Boehringer Ingelheim, our teams are also fully committed to promote Entresto®“, he added.

Record changed: 2018-01-02


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Servier (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top